Are Peanuts Good for Weight Loss? Honest Evidence Review

The honest answer: nuanced yes. Whole peanuts are calorie-dense (~166 kcal per 1-ounce serving, ~585 kcal per 100 g) but the controlled-feeding RCTs and long-term cohort evidence converge on the same signal — people who eat peanuts regularly do not gain more weight than people who don't, and often gain less. The deciding variable is the handful, not the food. Per USDA FoodData Central (FDC 170161), 1 oz (28 g) of dry- roasted unsalted peanuts delivers ~166 kcal, ~7 g protein, ~14 g fat (mostly monounsaturated), ~6 g carbohydrate, and ~2 g fiber. The Alper & Mattes 2002 Purdue RCT^[1] added ~500 kcal/day of peanuts to free-living adults' habitual diets for 8 weeks; energy compensation was ~66% (subjects spontaneously ate less of other foods), resting energy expenditure rose modestly, and no significant weight gain occurred. The Traoret 2008 fecal-energy balance study^[3] estimated that about 17.8% of peanut energy is not absorbed — lost in feces rather than counted toward net intake — a smaller but still real version of the whole-almond malabsorption effect documented by Baer. The Mozaffarian 2011 NEJM analysis^[6] of 120,877 US adults across three Harvard cohorts found nuts associated with −0.57 lb of 4-year weight change per daily serving — one of the small set of foods (alongside fruits, vegetables, whole grains, yogurt) inversely associated with long-term weight gain. The Liu 2019 cohort analysis^[5] (n=148,839 across NHS, NHS-II, HPFS) showed peanut-specific intake increases tracked with −0.32 kg of 4-year weight change per 0.5-serving daily increase — actually a stronger inverse signal than peanut butter (−0.15 kg / 4-yr) in the same dataset, plausibly because the chewing-resistance and partial-malabsorption effects survive better in the whole nut than in the ground spread. Magnitude check: STEP-1 semaglutide^[7] produced −14.9% body weight at 68 weeks; SURMOUNT-1 tirzepatide^[8] −20.9% at 72 weeks. Peanuts do not approach that magnitude — no food does — but they survive portion control better than their calorie density suggests. The failure modes are real and important: aflatoxin in improperly stored stock, allergic anaphylaxis in the ~1.4% of US adults with peanut allergy, and the ballpark-bowl grazing pattern that turns 1-oz portions into 4-oz ones.

The honest summary

• USDA macros, 1 oz dry-roasted unsalted peanuts (28 g, FDC 170161^[10]): ~166 kcal, ~7 g protein, ~14 g fat (~7 g MUFA, ~4 g PUFA, ~2 g SFA), ~6 g carbohydrate, ~2 g fiber, ~1 mg sodium (unsalted; ~117 mg for salted). Per 100 g: ~585 kcal, ~24 g protein, ~50 g fat, ~21 g carb, ~8 g fiber.
• Alper & Mattes 2002 chronic-feeding RCT^[1]: 8-week free-living trial. Adults added ~500 kcal/day of peanuts to habitual diet. Energy compensation was ~66% — subjects spontaneously ate less of other foods so net daily intake rose by only ~170 kcal. Resting energy expenditure rose modestly. No significant weight gain. Canonical “peanuts don't make you fat” trial.
• Mattes 2008 J Nutr review^[2]: synthesis of peanut + tree-nut RCTs and cohorts. Mechanisms for the “calorie-dense food that doesn't drive weight gain” paradox: (a) high satiety per kcal from protein + fat + chewing resistance, (b) partial fat malabsorption from the intact cell-wall matrix, and (c) a modest diet-induced thermogenesis bump. The review concluded regular nut consumption is “not associated with weight gain and may aid in weight loss” in the controlled trials.
• Traoret 2008 fecal-energy study^[3]: measured digestible energy of peanuts in humans. About 17.8% of peanut energy escaped absorption and appeared in feces. The practical translation: a “166-kcal” ounce of peanuts delivers closer to ~137 net metabolizable kcal in typical eating. Smaller than the ~32% malabsorption Baer 2012 documented for whole almonds, but real and not zero.
• Bes-Rastrollo 2007 SUN cohort^[4]: n=8,865 Spanish university graduates, 28 months. Frequent nut consumers (≥2 servings/wk) gained ~0.78 kg less body weight and had 31% lower risk of gaining ≥5 kg vs non-/rare-consumers.
• Liu 2019 Harvard change-in-intake analysis^[5]: n=148,839 across NHS, NHS-II, HPFS. Each 0.5-serving/day increase in total nut intake associated with −0.19 kg of 4-year weight change. Peanut-specific: −0.32 kg / 4-yr — modestly stronger than peanut butter (−0.15 kg / 4-yr) at the same dose.
• Mozaffarian 2011 NEJM load-bearing cohort^[6] — n=120,877: three Harvard cohorts, 20-year follow-up at 4-year intervals. Nuts −0.57 lb per daily serving increase, alongside fruits, vegetables, whole grains, and yogurt as the foods most protective against long-term weight gain.
• Magnitude vs GLP-1s: peanuts are not pharmacotherapy. STEP-1 semaglutide^[7] −14.9% body weight at 68 weeks. SURMOUNT-1 tirzepatide^[8] −20.9% at 72 weeks.
• YMYL safety items: peanut allergy (anaphylaxis risk in ~1.4% of US adults), aflatoxin from improper storage (FDA limit 20 ppb; commercial US peanuts tested), and added-sodium load on salted/honey-roasted versions (~110–240 mg per oz).

What whole peanuts actually are

Peanuts are a legume, not a tree nut — the same family as beans, lentils, and chickpeas. That genetic distinction matters for two reasons. First, peanut protein density is higher than most true tree nuts on a per-100-g basis (~24 g vs ~21 g for almonds, ~9.5 g for pecans), which earns peanuts a clean role in the protein-budget math of a weight-loss diet. Second, peanut allergy is biologically distinct from tree-nut allergy and the two cross-react less often than the shared “nut allergy” label suggests.

Per 100 g of USDA-reference dry-roasted unsalted peanuts (FDC 170161^[10]), the macronutrient profile is ~50 g fat (~76% of calories), ~21 g carbohydrate (~15% of calories) including ~8 g dietary fiber, and ~24 g protein (~16% of calories). The fat is favorable: ~25 g monounsaturated (oleic acid, similar to olive oil and avocado), ~16 g polyunsaturated (~15 g linoleic acid), and only ~7 g saturated.

(1) The 1-oz serving is the operative portion. One ounce of peanuts is ~28 g — roughly a small handful, or ~28 individual peanut halves. That delivers ~166 kcal, ~7 g protein, ~14 g fat, ~6 g carbohydrate, and ~2 g fiber. The common eating context is the multi-ounce drift: a small bowl of bar peanuts averaged across a single sitting is commonly ~3 oz (~500 kcal). The Alper & Mattes 2002 energy- compensation evidence^[1] was measured at planned ~89 g doses with the rest of the day's eating self- regulated — not at continuous grazing.

(2) Protein per bite is meaningful, but the quality is moderate. Peanut protein digestibility-corrected amino acid score (PDCAAS) is ~0.52–0.70 — lower than animal proteins (whey 1.00, egg 1.00, milk 1.00) and lower than soy (~0.92). Peanut is limiting in lysine and methionine. Peanuts contribute usefully to a daily 1.6–2.2 g/kg protein target but should not be the primary protein source in a lean-mass-preservation plan.

(3) Fiber is real and not trivial. 2 g per oz is ~7% of the 28 g/day fiber target — modest, but the fiber density (~8 g per 100 g) is comparable to oatmeal and higher than most snack foods at this calorie level.

(4) Energy density is the load-bearing number. At 585 kcal per 100 g, peanuts sit near the top of the calorie-density tier — comparable to almonds (~598 kcal/100 g) and pistachios (~567 kcal/100 g), and lower than pecans (~691 kcal/100 g). The 1-oz-as-USDA-serving rule is real and the bowl-graze drift is the practical failure mode.

Magnitude comparison: peanuts vs other nuts and protein foods

Per 100 g, peanuts are ~10× the calorie density of non-fat Greek yogurt — the highest-protein-per-kcal whole-food option in the dairy aisle. But per gram of protein, peanuts (~24 g protein / 585 kcal = ~24 kcal/g protein) sit respectably between the dense fat sources (pecans ~73 kcal/g protein, olive oil essentially infinite) and the lean protein foundations (Greek yogurt ~6 kcal/g protein). The use case where peanuts win is as a portable, shelf-stable protein- plus-fat anchor — most cleanly when measured by the ounce, not the bowl.

Satiety and energy compensation: the Mattes evidence base

The single most important paper in the whole-peanut weight- loss literature is Alper & Mattes 2002^[1] from the Purdue ingestive-behavior laboratory. The trial added ~500 kcal/day of peanuts (about 89 g, ~3 oz) to free-living adults' habitual diets for 8 weeks and measured what happened to body weight and total daily intake.

• Energy compensation: subjects spontaneously reduced intake of other foods by ~330 kcal/day. Net daily intake rose by only ~170 kcal — about 66% of the peanut calories were spontaneously compensated.
• Resting energy expenditure: rose modestly across the 8-week period, contributing additional kcal/day to the offset.
• Body weight: no statistically significant gain. The arithmetic-predicted weight gain from naively adding 500 kcal/day did not occur.

The Mattes 2008 J Nutr review^[2] synthesized the broader RCT + cohort literature on peanuts and tree nuts and identified three mechanisms behind the “calorie-dense food that doesn't drive weight gain” paradox: high satiety per kcal from the protein + fat + chewing- resistance combination, partial fat malabsorption (the cell- wall matrix of the intact nut traps fat in the stool), and a modest diet-induced thermogenesis bump. The review concluded that regular nut consumption is “not associated with weight gain and may aid in weight loss” in the controlled trials.

The honest read: the satiety + energy-compensation effect of whole peanuts is real and replicated. It is also partial — about two-thirds of added peanut calories are compensated for, not all. Adding peanuts on top of an otherwise-unchanged diet can still add 50–150 net kcal/day, which compounds slowly. The substitution use case (peanuts in place of crackers, chips, or sweets) bypasses this risk; the addition use case (peanuts as a fourth snack on a four-snack-already day) is where calorie drift quietly accumulates.

The Traoret 2008 calorie-absorption story

Traoret 2008^[3] measured the digestible energy of peanuts in a controlled human feeding protocol with stool collection. Subjects consumed peanuts and the resulting fecal energy content was measured by bomb calorimetry. The result: roughly 17.8% of peanut energy was not absorbed and appeared in feces — lost rather than counted toward net metabolizable intake.

The practical translation is that a “166-kcal” ounce of peanuts on the USDA label is closer to ~137 metabolizable kcal in typical eating. The size of the effect is smaller than the ~32% malabsorption Baer 2012 documented for whole almonds (where the cell-wall density is higher and the fat is harder to extract), but it is not zero, and it helps explain why the cohort and RCT data on peanut consumption do not match what naive kcal arithmetic would predict.

Two important caveats. First, peanut butter loses much of this effect — grinding ruptures the cell walls and frees the fat for absorption. Liu 2019^[5] showed peanut butter at −0.15 kg / 4-yr vs whole peanuts at −0.32 kg / 4-yr per 0.5-serving daily increase. Second, the malabsorption is a population-average estimate; it cannot be invoked as a kcal-discount on any individual portion. If you weigh 1 oz of peanuts and log 166 kcal in a tracker, the modest under-absorption is already baked into the multi-year cohort signal — you do not get to subtract it twice.

Long-term cohort data: whole peanuts inversely associated with weight gain

The cohort evidence on peanut and nut consumption is unusually consistent across populations and decades. The signal: people who eat peanuts regularly gain less weight over years than people who don't.

Bes-Rastrollo 2007 SUN cohort^[4] — n=8,865 Spanish university graduates, 28 months. Subjects consuming ≥2 servings of nuts per week gained ~0.78 kg less body weight and had 31% lower risk of gaining ≥5 kg vs non-/rare-consumers. The signal survived adjustment for age, sex, baseline BMI, physical activity, smoking, and total energy intake.

Liu 2019 Harvard change-in-intake analysis^[5] — n=148,839 across the Nurses' Health Study, NHS-II, and the Health Professionals Follow-up Study. Each 0.5-serving/day increase in total nut intake associated with −0.19 kg of 4-year weight change. Peanut-specific increase: −0.32 kg / 4-yr — a stronger inverse signal than peanut butter (−0.15 kg / 4-yr) at the same dose, consistent with the chewing-resistance and partial-malabsorption mechanisms being intact in the whole nut and partially lost in the ground spread.

Mozaffarian 2011 NEJM^[6] is the load-bearing reference because of its sample size and the way it benchmarks foods against each other. Across the three Harvard cohorts (n=120,877), foods most positively associated with 4-year weight gain per daily-serving increase were potato chips (+1.69 lb), potatoes (+1.28 lb), sugar-sweetened beverages (+1.00 lb), and unprocessed red meats (+0.95 lb). Foods most inversely associated were yogurt (−0.82 lb), nuts (−0.57 lb), fruits (−0.49 lb), whole grains (−0.37 lb), and vegetables (−0.22 lb). Nuts landed firmly on the protective side, ahead of fruits, whole grains, and vegetables on a per- serving basis.

The standard observational-nutrition caveats apply: people who eat more nuts likely cluster with other health-positive behaviors. But the consistency across cohorts, populations, and study designs — combined with the controlled-feeding RCT evidence — makes whole peanuts one of the better-evidenced “safe” calorie-dense foods in the weight- management literature.

YMYL safety: allergy, aflatoxin, and storage

Three peanut-specific safety considerations matter enough to list explicitly. None of them apply to most consumers, but each has a non-zero base rate and is the kind of detail general “is X good for weight loss” content commonly omits.

(1) Peanut allergy. Approximately 1.4– 2% of US adults have a clinically diagnosed peanut allergy. Reactions range from mild oral itching to anaphylaxis. Peanut allergy is biologically distinct from tree-nut allergy (almonds, walnuts, pecans, etc.) and the two cross-react less often than the shared “nut allergy” label suggests. If you have a diagnosed peanut allergy, no weight-loss benefit overrides the anaphylaxis risk — substitute tree nuts (after individual tolerance testing) or sunflower seeds. If you suspect a reaction to peanuts and have never been formally tested, see an allergist before re-introducing them — this is not a self-diagnosis category.

(2) Aflatoxin. Aflatoxins are toxic metabolites produced by Aspergillus flavus and related molds that can grow on improperly stored peanuts (and corn, tree nuts, dried figs, spices). High chronic aflatoxin exposure is a documented hepatocarcinogen. The US FDA action level for aflatoxin in peanuts and peanut products is 20 parts per billion (ppb); commercial US peanuts are routinely tested and compliant batches are well below toxicological thresholds for typical Western consumption. Aflatoxin concerns are higher in regions without enforced agricultural standards and in peanuts stored long-term in humid conditions. For US consumers buying commercial peanuts and storing them in sealed containers in a cool dry place, aflatoxin is not a meaningful weight-loss decision factor. If you grow or buy peanuts informally, store them dry, discard any with visible mold or off-flavors, and rotate stock.

(3) Added sodium. Salted dry-roasted peanuts commonly run ~117 mg sodium per ounce; honey-roasted and flavored versions can hit 200–240 mg/oz. For most weight-loss eaters this is incidental, but on a sodium- restricted diet (heart failure, hypertension at goal, kidney disease) the unsalted version is the obvious default. Cocktail and bar mixes can stack additional oils, sugars, and seasonings that change the food entirely — read the label.

Peanuts on a GLP-1: practical use

For patients on semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro), whole peanuts have practical attributes worth flagging, plus the same portion-control traps that matter more at reduced total intake. The Wharton 2022 clinical practice guidance^[9] on managing GI side effects of GLP-1 receptor agonists frames the food-pairing rule: small portions, paired protein + fat + fiber, slow eating. Peanuts fit that pattern cleanly when measured.

• Protein per bite is meaningful. At ~7 g of protein per ounce, peanuts contribute modestly toward the 1.6–2.2 g/kg/day target that underpins lean-mass preservation. The SURMOUNT-1 DXA-substudy data indicate 25–39% of weight lost on GLP-1s is lean mass (see our semaglutide muscle-mass review); high-protein-per-bite palatable foods earn a place in the eating pattern.
• Small physical volume. 1 oz of peanuts is ~28 g by weight and small by volume. GLP-1-induced delayed gastric emptying makes high-volume foods uncomfortable; a small, calorie-dense, protein-containing handful is often better tolerated than 1.5 cups of Greek yogurt or 4 oz of chicken, especially in the nausea-dominant phase of titration.
• Pair, don't graze. The Wharton 2022 pattern^[9] — protein + fat + fiber, small portion, slow eating — is well-served by a 1-oz peanut serving with apple slices or a small Greek yogurt. A continuous “handful from the jar” pattern is where the calorie drift quietly erases the GLP-1-induced appetite suppression.
• Calorie density is the load-bearing trap. At 585 kcal per 100 g, peanuts are one of the most calorie- dense whole foods you can keep at hand. On a typical GLP-1 reduced intake of 1,200–1,500 kcal/day, a 1-oz handful is 11–14% of the day's calories; an eyeballed “couple of ounces” is 22–28%. The energy-compensation evidence from Alper & Mattes 2002^[1] was measured in free-living adults at normal appetite levels; that mechanism is meaningfully different on a GLP-1 because total daily intake is already pushed below baseline by the drug.

See our full GLP-1 protein-first eating guide for the broader meal-pattern context where peanuts sit as a protein-and-fat side, and our exercise pairing on a GLP-1 for the resistance-training protocol the lean-mass- preservation framework rests on.

Magnitude check vs Wegovy and Zepbound

The pharmacologic columns reflect −15 kg and −21 kg of body weight respectively at 100 kg starting weight. The nut signal — a quarter kilogram of avoided weight gain per daily serving over four years — is consistent and replicated across cohorts and study designs, but it is not in the same magnitude tier as obesity pharmacotherapy. The honest framing: peanuts are a food that survives portion control without sabotaging weight loss, with a modest favorable nudge. They are not a weight-loss intervention.

Common bad takes

(1) “Peanuts are fattening.” Not supported by the controlled-feeding or cohort evidence. Alper & Mattes 2002^[1] added ~500 kcal/day of peanuts to free-living adults for 8 weeks and observed no significant weight gain. Mozaffarian 2011^[6] showed nuts inversely associated with weight gain across 120,877 US adults. Liu 2019^[5] showed peanut-specific intake increases tracked with −0.32 kg / 4-yr per 0.5-serving daily increase. The “peanuts make you fat” framing is wrong at the population level.

(2) “Peanuts burn fat / are a fat-loss food.” Equally wrong in the other direction. No food “burns fat” in any meaningful physiological sense. The modest rise in resting energy expenditure documented in Alper & Mattes 2002^[1] was a partial offset of added calories, not a net negative-calorie effect. Peanuts are portion-controllable and satiating, not metabolically magical.

(3) “Raw peanuts are dangerous because of aflatoxin.” Overblown for commercial US peanuts. The FDA action level is 20 ppb and commercial batches are routinely tested. Raw vs roasted is not the decisive variable; storage condition is. Store peanuts dry, sealed, and rotate stock. Discard any with visible mold or off-flavors. The aflatoxin concern is real in regions without agricultural standards and for poorly stored stock — not for the median US consumer eating a commercial bag.

(4) “Peanuts aren't real nuts so they don't count.” Botanically true (peanuts are legumes), nutritionally a distinction without a weight- loss difference. The cohort signals on “nuts” in Mozaffarian 2011^[6] and Liu 2019^[5] include peanuts; the Liu peanut-specific subgroup is protective at −0.32 kg / 4-yr per 0.5-serving daily increase. Eat peanuts as you would any other nut at the same portion.

(5) “Honey-roasted peanuts are just as good as plain.” Different food. Added sugar (commonly 2–5 g per oz) and added sodium (200–240 mg per oz) change the macros and the snacking dynamics. Plain dry-roasted unsalted or lightly salted is the default that matches the cohort and RCT literature; honey-roasted is a sweetened snack that happens to contain peanuts.

(6) “A handful of peanuts before bed helps you lose weight.” Wellness folk wisdom, no peer- reviewed evidence for the timing claim specifically. The energy-compensation effect from Alper & Mattes 2002^[1] covers about 66% of added calories in free- living adults; on a calorie-deficit diet the offset is likely smaller, and on a GLP-1 it may be smaller still. A pre-bed handful is fine if it fits the day's calorie target; it's not a metabolically privileged eating window.

What this isn't

Whole peanuts are not a weight-loss food. They are a weight-loss-compatible food — high in protein and satisfying fat, low in glycemic impact, partially malabsorbed, and consistently inversely associated with long-term weight gain in the cohort data. Substituted in for sweetened snacks at matched calories, they earn a clear place. Added on top of an unchanged diet without portion control, they quietly drift the daily total upward and contribute to slow weight gain.

The interventions that actually move the needle on body weight at the magnitudes patients want are caloric deficit and obesity pharmacotherapy. GLP-1 receptor agonists (STEP-1 semaglutide^[7] −14.9% body weight at 68 weeks; SURMOUNT-1 tirzepatide^[8] −20.9% at 72 weeks) sit in a different magnitude tier than any food choice. Peanuts are an item on the grocery list. They are not the plan.

Last verified: 2026-05-28. Next review: every 12 months, or sooner if new RCT evidence on whole-peanut consumption and weight outcomes is published.